SCHEMBL6492912

SCHEMBL6492912

CCOc1ccc(CO)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NQO1 P15559 1/20 0.45
HIF1A Q16665 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784748 0.89 KDM4E (0.53) KDM4ENQO1TP53MAPTTSHR
SCHEMBL16959703 0.86 HSD17B10 (0.47) KDM4ENQO1HIF1APDE4APDE4B
SCHEMBL13634446 0.85 APLNR (0.50) APLNRKDM4ENQO1HIF1ATAS1R3
SCHEMBL238087 0.85 APLNR (0.63) APLNRPDCD1CD274KDM4EPDE4A
SCHEMBL27315198 0.83 MEN1 (0.46) APLNRKDM4EHIF1ATAS1R3TAS1R1
SCHEMBL701717 0.82 APLNR (0.47) APLNRKDM4ENQO1HIF1ATAS1R3
SCHEMBL19231006 0.81 APLNR (0.44) APLNRPDCD1CD274TAS1R3TAS1R1
Hydrochloric Acid SCHEMBL2944977 0.81 MELK (0.46) APLNRKDM4ENQO1HIF1ATAS1R3
SCHEMBL2016744 0.80 CNR2 (0.46) APLNRPDCD1CD274PDE4APDE4B
SCHEMBL12637177 0.80 APLNR (0.42) APLNRPDCD1CD274PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197477-A1 PHOSPHONIUM SALTS DERIVATIVES VALORISATION-RECHERECHE (CA) 2007-08-23 US disclosed
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed
WO-2004108686-A2 BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197477-A1 PHOSPHONIUM SALTS DERIVATIVES PI4K2A, PIP4K2A, PI4K2B APLNR 4354/4885PDCD1 4669/4885CD274 4606/4885
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD APLNR 4858/4885PDCD1 3315/4885CD274 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.